These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29951367)

  • 1. Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease.
    Lv S; Jiang S; Liu S; Dong Q; Xin Y; Xuan S
    J Clin Transl Hepatol; 2018 Jun; 6(2):217-221. PubMed ID: 29951367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic evaluation of nonalcoholic fatty liver disease.
    Lee SS; Park SH
    World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis.
    AlShaalan R; Aljiffry M; Al-Busafi S; Metrakos P; Hassanain M
    Saudi J Gastroenterol; 2015; 21(2):64-70. PubMed ID: 25843191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
    Kaswala DH; Lai M; Afdhal NH
    Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver fat quantification: where do we stand?
    Starekova J; Reeder SB
    Abdom Radiol (NY); 2020 Nov; 45(11):3386-3399. PubMed ID: 33025153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease.
    Lee SJ; Kim SU
    Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):523-530. PubMed ID: 31018719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
    Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.
    Zhang JZ; Cai JJ; Yu Y; She ZG; Li H
    Gene Expr; 2019 Nov; 19(3):187-198. PubMed ID: 31010457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease.
    Roldan-Valadez E; Favila R; Martínez-López M; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2008; 7(3):212-20. PubMed ID: 18753987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of imaging in nonalcoholic fatty liver disease.
    Li Q; Dhyani M; Grajo JR; Sirlin C; Samir AE
    World J Hepatol; 2018 Aug; 10(8):530-542. PubMed ID: 30190781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).
    Han MA; Saouaf R; Ayoub W; Todo T; Mena E; Noureddin M
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):379-390. PubMed ID: 28277807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.
    Koplay M; Sivri M; Erdogan H; Nayman A
    World J Hepatol; 2015 Apr; 7(5):769-76. PubMed ID: 25914777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.
    Papatheodoridi M; Cholongitas E
    Curr Pharm Des; 2018; 24(38):4574-4586. PubMed ID: 30652642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in noninvasive methods for diagnosing nonalcoholic fatty liver disease.
    Shen FF; Lu LG
    J Dig Dis; 2016 Sep; 17(9):565-571. PubMed ID: 27429213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content.
    Zhang B; Ding F; Chen T; Xia LH; Qian J; Lv GY
    World J Gastroenterol; 2014 Dec; 20(47):17985-92. PubMed ID: 25548498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.